Hitherto behavioural investigations with reserpine have been confined to the use of very small doses, doses which weight for weight are considerably lower than those used in clinical work. Sidman (1956) used a Skinner lever pressing apparatus for investigating the effect of up to 0 1 mg./kg. reserpine on work under different reinforcement programmes. Smith, Wagman, Wagman and Riopelle (1956) , investigating the effects of reserpine on conditioned avoidance behaviour in monkeys with brain lesions, used doses between 0415 and 0-37 mg./kg. However, pharmacologists have reported interesting effects with more substantial doses in a variety of species. In particular, attention can be drawn to the atypical sedation induced by the drug. Unlike other depressants of the central nervous system, e.g., barbiturates, reserpine produces no anaesthesia, as animals can always be roused by external stimulation. Further, a paradoxical behaviour and electro-encephalographic pattern appears. Rats, for example, appear chronically sedated to the observer but have an alerted E.E.G. At the same time the limbs of drugged rats can be positioned in catatonic-like postures, deep body temperature falls steeply, and the sympathetic division of the autonomic nervous system appears to be blockaded. Subsequent reports will deal with experiments designed to determine the connexion between the pharmacological and physiological properties of the drug and behaviour. The present paper is concerned with accounts of the drug concentrations and the time factors which are involved in a behavioural disturbance induced with reserpine. In order to accomplish this it was necessary to discover the course of the reserpine disturbance in the rat the onset, the duration, and the time of recovery-by employing some behavioural criterion. For this purpose two measures were employed, response latency, that is, the time taken by the rat from the moment of entry into the apparatus to when it began to run, and a locomotor time score obtained from a straight runway apparatus. It was held that latency could be taken as the time required for the rat to organize its response in a given situation. In view of the known high specificity of reserpine treatment on the central nervous system it was postulated that this measure would be adequately sensitive. Locomotor efficiency was tested by measuring the time taken by the rat to move over a fixed distance. A 100 decibel mixed frequency noise generator was used to induce running behaviour in the apparatus after a criterion latency time had been exceeded. Design A concomitant variation design was used for this experiment. The work was spread out over three weeks, with the middle week as a control period, in order to ensure that there would be no carry-over effect in the treatment in the first week to the third week. The design is set out in Table I . The behavioural measures employed were latency of response and running time. The two controls were, first, the vehicle in which the reserpine raw material was dissolved,* and secondly, an equal volume of distilled pyrogen-free water. Owing to the long delay found in the drug's onset, and the relatively large number of animals treated, it was decided to test the drug's activity every quarter of an hour after injection.
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The number of test-hours was limited to five. Pilot runs with scrub animals showed that recovery could not be expected for from 24 to 36 hours. On the morning after treatment, i.e., 22 hours, rats were placed in the apparatus every hour and tested for recovery.
All animals were randomly assigned to a particular treatment. Litter mate controls were not considered. After each part of the experiment had been concluded all rats were again assigned at random for the new treatment and rested for seven days, although they were maintained on running schedules. One of the complex *The reserpine raw material employed in the first week of the experiment was kindly supplied by CIBA Laboratories. The reserpine was made up in an appropriate injection vehicle.
The formula employed was:- problems which bedevils this type of study is to select the correct, i.e., suitable for the experimental requirements, range of drug dosage levels. If one considers the intensity of the effect of the drug as being related to its concentration in the body, then the intensity may vary from the imperceptible to one which is so severe as to be useless. Hence 10 mg./kg. of reserpine, while not fatal, produces symptoms of such apparent severity that the rat, which is violently ill for several days, is useless for the continuation of the experiment. The range of drug concentrations was selected so that in the first experimental trials the dosages were worked up in geometric progression, from a dose level known from the pilot work to be ineffective. In the second experimental trials the dosages were worked down in a geometric progression from a known high level, that is 10 mg./kg. This procedure permitted a most economic sampling along the drug dosage continuum. A noise generator was employed in order to test the susceptibility of drugged rats to auditory stimulation.
Subjects
The subjects of these experiments, 20 male albino rats obtained at weaning, were from the Medical Research Council Toxicology Unit, Carshalton, Surrey. The animals were uniformly handled and treated throughout the experiment. They were fed on the approved Medical Research Council diet 41B (Bruce and Parkes, 1949) . At 80 days the rats were placed on a two-hour feeding schedule. Training in the apparatus started at the age of 100 days. Experimental and control injections were made intraperitoneally.
Procedure and Apparatus
Experiments were conducted in a 21-metre runway under hunger motivation. All aspects of this procedure and the apparatus have already been described in detail (Glow, 1957) .
The Effect of Reserpine on Behaviour
In the rat, reserpine produces a state of relative immobility associated with some degree of peripheral tremor. The rat's body is hunched tightly together, with the head sagging to the floor. The back legs are splayed out, probably in order to balance the body weight adequately ( Fig. la and b (Tasher and Chermak, 1955 Fig. 2b is tolerated for as long as the experimenter is prepared to hold the rat. Particularly noteworthy is the position of the head in this figure. When using ether or barbiturate sedation the head sags between the shoulders when the rat is held in this position.
The effect of auditory stimulation is difficult to assess. Rats make no attempt to move away from a source of noise of approximately 100 decibel mixed frequency, there being no head deflection. It was possible that the external pinnae moved to locate the source of the sound, but such movements were confused by the tremor and spasmodic jerking of the head. There was some tendency during the noise for the hyperkinetic symptoms to increase, the incidence falling off when the noise was switched off.
The effect of visual stimulation was difficult to evaluate. The eyes are generally completely shut by the drug's effect. A 100-watt light source brought close to the rat's eyes causes no head deflection. On the other hand rats appear to avail themselves of the light as a source of heat. One of the most remarkable features of this tranquillizing agent is the paradoxical aggression produced 24-36 hours after administration to the albino rat. If the rat is disturbed at this time it will indiscriminately and viciously attack the experimenter or any item introduced into the cage with a fury seldom seen PETER H. GLOW among normal tamed laboratory rats. This phase wears off quickly and the animal resumes its usual posture and tremor. This aggression can also be invoked by relatively light stimulation of, e.g., the vibrassae. An interesting fact is that once such an aggression has taken place, it does not occur again even with quite painful stimulation.
Results
The results from this preliminary experiment fall into two kinds; those which compare the controls, and the effect of the drug, and those which are concerned with the differential effects of the drug on various treatment groups. In Table II is shown the mean scores of two groups of 10 rats. These constitute the two control groups. The table is comprised of 20 scores, progressively arranged, so that each score is a sample of the rat's behavioural capacity, taken at quarter-hour intervals from the time of injection.
By inspection it would appear that there is no difference in the effects of the two treatments. The animals rapidly settled down to a fairly steady level of performance, which was maintained for a number of hours. In all the observations given, it is difficult to use a convenient statistic to calculate possible significant differences between groups. This is due to the dependence that exists between successive observations on the same subject. In order to offset the statistical difficulty encountered, a test of Table LI, it is apparent that the behaviour changes can be safely attributed to the effects of reserpine.
It was thought instructive to examine the data from the experimental groups and test the null hypothesis that there was no relation between all the treatment groups and the behaviour breakdown observed. The data have been set out in a 2 by 2 table in Table IV . (Siegel, 1956) can be used to determine the assumption that the treatment of Experimental Group VIHI (5 mg./kg.) will have the slower rate of recovery. This test yielded a U = 3. This result can be held to be significant at the 3% level on the one-tailed test (Siegel, 1956) . Only latency times are specifically dealt with in this section. Running times are not considered, as they yielded very much the same level of information, without adding fresh substance to the arguments raised in the discussion. found that reserpine (0 4 mg./g.) reduced the noradrenaline concentration of the cat's hypothalamus from its normal 1-4 ,ug./g. fresh tissue to b-ftween 0-2 and 0-6 ,tg/g. These results have been confirmed by Shore, Olin, and Brodie (1957) in the rabbit.
An attempt can be made to relate these biochemical findings to the behaviour. In Fig. 3 the graph is designed to show the time relationship between the fall in 5 HT and noradrenaline con- centrations and the rates of recovery in conjunction with the latency data reported in this experiment.
With the precaution in mind that this approximation involves different species it can be seen that the behavioural effects are roughly correlated to specific changes in the biochemistry of the central nervous system rather than to the specific effect of reserpine. A second interesting correlation can be made between the dosage levels of reserpine found in this experiment to have dramatic consequences on behaviour and the noradrenaline and 5 HT levels in the brain-stem four hours after the administration of equivalent doses (Fig. 4) . One important factor must be considered in evaluating these biochemical effects in relation to behaviour. While in the case of 5 HT there is apparent depletion in cerebral concentrations there is, however, actually an increased turnover rate of the compound as distinct from noradrenaline activity which only shows a depletion. Udenfriend, Weissbach, and Bogdanski (1957) have provided evidence that potentially more 5 HT can be destroyed than can be made in a given time. As 5 HT continues to be formed, though no longer bonded, owing to the reserpine effect, there exists not only a high level of 5 HT activity, but also a very rapid turnover of this substance. These authors have demonstrated with radioactive studies that the halflife of cerebral 5 HT is of the order of one to two hours. Thus, though at any particular moment the 5 HT assay reveals a relatively low cerebral concentration of 5 HT after the administration of reserpine, in point of fact the activity and turnover is increased many times.
From the consideration of the biochemical and behavioural evidence the following at least tentative conclusions can be drawn:
(1) The behavioural decrements found with reserpine treatment cannot be ascribed to the specific action of this drug per se.
(2) The decrements as measured in this experiment are related in time to changes in 5 HT and noradrenaline activity in the central nervous system.
(3) There is some indication that while noradrenaline levels are relatively depleted there is an increased turnover of cerebral 5 HT.
The effects of reserpine on other amines has as yet not been investigated, though it is not unlikely that these would also show some change. The behavioural disturbances induced are associated with a number of marked physiological changes, such as a fall in deep body temperature and an extrapyramidal syndrome and a blockade of the sympathetic system. In Part II these physiological factors will be examined and some attempt will be made to examine these as the possible causal factors underlying the behavioural response of the rat to reserpine. Three sets of experiments are reported in which several plausible hypotheses are advanced and investigated. In all cases the rats were tested for the effects of the treatment on latency and running times, as this procedure has been shown to be sensitive to the effects of drugs which affect behaviour.
Experiment I One of the most striking syndromes induced by reserpine is an overactivity of the extrapyramidal motor system. This is indicated by the presence of a rhythmic alternating tremor in the region of the head and neck with an apparent paralysis of the limbs. This latter state is also associated with a rigidity in the limbs on passive movement. Owing to the disturbance the rat can be placed in catatoniclike postures. Similar accounts have been given of patients overdosed with reserpine (Kinross-Wright, 1955) . Such patients have developed a condition simulating paralysis agitans with paralysis of volitional movement. Spontaneous recovery occurred when the drug was withheld from patients. In these circumstances it was thought not unlikely that the total behaviour breakdown found in the experimental situations with the rat may be attributed to a motor paralysis of central origin.
Experimental neurophysiological studies implicate the involvement of subcortical structures in the aetiology of paralysis agitans. Jenkner and Ward (1953) found that high frequency electrical stimulation of any part of the medial reticular formation of the brain-stem in monkeys produced a rhythmically alternating peripheral tremor analogous to paralysis agitans. These experimentally evoked tremors could be reduced or abolished by the administration of anticholinergic drugs, in particular those drugs which are clinically most useful in the symptomatic and palliative treatment of Parkinson's syndrome. These results were confirmed and elaborated by Rinaldi and Himwich (1954) . Rinaldi and Himwich (1955) were also able to show that reserpine administration (0-05 mg./kg.) produced an altered E.E.G. and demonstrated that this arose from an activating system which included the reticular formation.
It was supposed largely on empirical grounds that, if remission of symptoms can be produced with atropine in both the clinical condition and in the simulated disorder, a similar effect may be derived in the pharmacologically induced condition. The hypothesis formulated was that the symptomatic relief of the motor condition in the rat may be instrumental in producing a "normalized"' behavioural response.
Design.-This experiment took place over five days. One rat from each of the two treatment orders was employed on every experimental day. In the experimental design five rats were randomly assigned to each of two treatment orders. In the first treatment order atropine was administered, followed an hour later by the injection of reserpine. This treatment was succeeded by a control injection of water. In the second treatment order a control injection of water was administered followed an hour later by the injection of reserpine. This treatment was concluded by the injection of atropine. Latency and running time measures were taken quarter-hourly throughout the experiment.
The design can be graphically presented as follows:- The design serves the twofold purpose of testing whether atropine had a prophylactic and/or therapeutic effect on reserpine-induced locomotor disturbance, and at the same time permits the two treatment orders to be used as mutual controls.
The drug dosages were made up as follows: Reserpine, 5 mg./kg., and atropine sulphate in a distilled water solvent, 120 mg./kg., were made up in I ml. volume and injected intraperitoneally. Distilled pyrogen-free water was administered as a control in a volume of 1 ml. The use of 5 mg./kg. reserpine was designed to permit performance comparisons to be made with the data from previous experiments. In particular the catatonic-like behaviour found with the use of this dosage level could be reproduced. The dosage of atropine sulphate was determined on normal scrub rats. These animals were injected with varying doses and tested for any resultant violent motor excitation. It was found that with doses much over 150 mg./kg. some excitation occurred. The actual tolerance level of atropine in the rat is very high, in the region of 500 mg./kg. intraperitoneally (Willberg, 1914 Group A treatment order (atropine-reserpine-water). Group B treatment order (N%ater-reserpine-atropine).
Discussion.-The results are clearly against the hypothesis as formulated. It is therefore necessary first to consider the efficacy of the atropine treatment, and secondly the premises on which the hypothesis was founded.
The failure of atropine to alter the effects of reserpine treatment could be considered as being due to the inadequacy of atropine per se. Ambache (1955) , in his review on the use and limitations of atropine, lists a number of possibilities which could account for specific resistance to atropine, e.g., the presence of the specific enzyme atropinesterase. These, however, are not applicable in this case for a number of reasons: for example, atropine produced a pupil dilatation and appeared to inhibit salivary secretion which was a feature of reserpine medication. The administration of atropine appeared to reduce the incidence of spontaneous hyperkinetic movement, catatonic-like positioning became impossible, and resistance in the limbs was not felt on passive movement. From these factors it can be assumed that atropine had an effect on the organism, but not the specific effect anticipated, namely, a recovery in normal movements. It is therefore highly probable that the premises concerning the effects of reserpine treatment require re-examination.
The basic assumption made in treating paralysis agitans, whether in the case of the clinical entity or experimentally produced lesions, is that damage in the lower diencephalon interrupts the motor fibres into the medial reticular formation. Empirically it is found that the resulting motor disorder can be ameliorated by the administration of atropine or atropine-like agents. Jenkner and Ward (1953) suggested that the deafferented cells in the reticular 3 formation subsequently become hypersensitive to the locally liberated acetylcholine, and further that atropine exerted an anticholinergic effect at this site. These arguments tend to indicate that the motor disorder is related to the predominating effects of the cholinergic neurohumoral mechanism. Reserpine, however, produces no lesions (except perhaps in the biochemical sense) in the basal ganglia, nor is the neurohumoral apparatus necessarily adapted to a higher level of cholinergic activity. However, changes in neurohumoral balance do occur as a consequence of administration of reserpine. These changes are predominantly in the direction of a diminution in the sympathetic or adrenergic neurohumoral activity. A reduction in the adrenergic system produces symptoms which could be described as being parasympathetic-like. With this point in mind it could be considered that the approach employed in this experiment is in the wrong direction, namely the use of an anticholinergic agent should be replaced with the use of an adrenergic-like agent. Some support for this argument will be found in a subsequent experiment reported in this paper.
The hypothesis that the extrapyramidal syndrome observed as a consequence of reserpine administration is related to the cessation of locomotor behaviour is not justified by the findings in this experiment. Atropine was found to alleviate the hyperkinesis, but did not restore the rat to a " normal " level of behaviour. It was also considered probable that a different direction would have to be taken to locate the neurohumoral factors which could be causal to the reserpine-induced behaviour disturbance.
Experiment II An alternative mechanism proposed was one arising out of profound changes in thermoregulatory control. Invariably, reserpine depresses the body temperature, the effect being central in origin. There is considerable evidence in the general literature (Burton and Edholm, 1955) curative fever treatment is employed, e.g., neuroThere are two ways in which this problem can be syphylis. For this malarial treatment has been examined. In both methods the essential technique conventional. In recent years it -has been found is to reverse the thermal gradient in a manner such advantageous to use specific pyrogenic agents. The that the animal's deep body temperature returns to agent used in this experiment was "pyrifer", an normal. First, it is possible to reverse the external albuminous substance obtained from Bact. coli., a thermal gradient, whereby the rat gains heat, and non-pathogenic race of microbes. A number of secondly, one can alter the thermoregulative preliminary trials were attempted on scrub rats in mechanism whereby the rat generates more heat.
order to determine the number of units (each In order to investigate this problem the first unit = 1,000,000 germs per ml.) required to raise experiment comprised an attempt to alter the the reserpine-depressed temperature to a " normal external thermal gradient. The requirements are level ", i.e., 37.50 C. The observation made with a basically simple, but were difficult to make effective. population of normal but identical strain showed Five rats were treated with 5 mg./kg. reserpine. By that the mean rectal temperature was 37.50 C. with six hours, the deep body temperature had fallen by a variation ± 30 C. This substantially agrees with 2 to 30 C. These animals were placed in the latency the observations made by Pembrey (1895) on albino box of the apparatus, under conditions and training rats. It was found in practice that 1,000 units procedures that were identical with those used injected intravenously three hours after reserpine hitherto. The back of each experimental animal was raised the temperature to " normal levels ". It was approximately 2 in. from a continuously radiating considered desirable to compare the deep body heat source. The laboratory was thermostatically temperatures of one group of rats, while simulregulated, the room temperature being set at taneously testing the behaviour on a litter mate 200 C. ± 30 C. Level with the rat's back, an ambient group. thermometer was placed in such a manner that the distance of the heat source could be varied to give a Design.-Five male litters were obtained from the constant temperature of 600 C. It was found that a same source as in all previous experiments. Each group distance of 6-5 cm. between the heat source and the comprised four rats; litters were divided randomly but r evenly into four populations and assigned orders. rat gave a stea y environmental temperature of Group A was composed of animals which were treated 60~C., within 7 minutes 45 seconds. This gave a with 5 mg./kg. reserpine. After three hours, 1,000 units of positive heat gradient from 600 C. on the fur to a pyrogenic agent were given intravenously. Rectal temdeep body temperature of approximately 35.40 C. peratures were recorded every hour for eight hours on It was found in practice that within 15 minutes the the first day. On the second day temperatures were deep body temperature rose to 37-5 and 38.50 C. recorded every three hours. Group B was composed Rats were continuously observed from 30 to of animals which were treated with 5 mg./kg. 45 minutes with a raised deep body temperature. reserpine. After three hours an equivalent volume The observations made with this technique gave a of pyrogen-free distilled water was injected in- changes occurred which could be associated with reserpine, and after three hours all animals received thermoregulatory failure as such. It was found that 1,000 units of the pyrogenic agent. Observations on animals made no attempt to initiate locomotor latency and running times were made every half hour behaviour, demonstrated no interest in food, and for eight hours. Group D animals were treated with were still catatonic-like when handled. 5 mg./kg. reserpine. After three hours all rats received There were, however, very many objections to this 2 ml. pyrogen-free water intravenously. Observations crude procedure. Rats with hypothermia are more were made as in Group C above. The animals in Groups likely to remain within the immediate vicinity of the C and D were trained and treated in the fashion reported heat source ratherthan move along the runway, in all previous experiments. The environmental temheat source rather than move along the runway, perature throughout the experiment was 20°+ 30 C. for even if the length of the runway has the same all groups. positive thermal gradient. This observation confirms the results found by Schwartzbaum (1955) Results.-The effect of the treatment as outlined that rats treated with reserpine showed marked in groups A and B may be found in Table VII and thermal preferences, in that they remained in the groups C and D in Table VIII. vicinity of a given heat source. It was consequently It will be readily seen that no difference exists thought desirable to attempt an alternate means of worthy of note between the onset rate in the reserreadjusting the deep body temperature by artificially pine behaviour decrement of either group C or D.
raising it internally.
Moreover, there was no change in the total cessation 20 PETER H. GLO W (Fig. 5) . PETER H. GLOW proportional to the degree of hypothermia. By raising the ambient temperature they found that reserpine was no longer hypothermic or sedative. However, these authors were testing the effects of reserpine on prolonged pentobarbitone hypnosis which entails the problem of drug interaction. It is obvious that the techniques employed to test this hypothesis were inefficient. However, through these experiments and many pilot attempts no evidence could be produced which warranted taking this problem any further.
Experiment III The third alternative mechanism proposed arose out of considerations involving the general pharmacological properties of reserpine. The general conclusions derived from these studies tended to indicate that reserpine induced a shift in the normal balance between the cholinergic and the adrenergic neurohumoral systems (Bein, 1956 ). In particular it was suggested at the time that reserpine inhibits the sympathetic outflow and has no particular stimulating property for the parasympathetic hypothalamic centre. The result of reducing sympathetic activity is an increase in parasympathetic tone. It is possible to consider that by offsetting the reduced activity of the adrenergic neurohumoral mechanism, as for example with a sympathomimetic agent, that a balanced neurohumoral picture will result. Under these circumstances the behavioural components of reserpine administration could be expected to show a remission for the duration of the action of the sympathomimetic drug. A secondary consideration for which some material may be obtained from such an experiment concerns the problem of isolating out the plausible neurohumoral factors involved. There is as yet no reliable information as to the chemical mediators in the central nervous system. A suitable sympathomimetic agent was obtained from CIBA.* Methyl phenidate (" ritalin ") was prepared as a synthetic analeptic drug. The stimulating properties of the central nervous system of this phenidate compound are similar in many respects to that of benzedrine and caffeine with several important differences. Methyl phenidate produces almost no peripheral sympathomimetic effects, e.g., there is no significant effect on blood pressure, respiration, and heart rate. Further, this drug produces none of the euphoric effects found with benzedrine or the circulatory reactions associated with caffeine. It was considered that the suitability of methyl phenidate as a reserpine antagonist could rest principally with the drug's specific central sympathomimetic effect.
The hypothesis was considered in the following terms. Reserpine shifts the neurohumoral balance toward an adrenergic deficit, at the same time inducing a marked behaviour change. The administration of a suitable sympathomimetic agent could redress this balance and restore the animal's capacity to respond to the experimental requirements.
Design.-The subjects of this experiment were 10 male rats. One control and one experimental group were employed. One animal from each group was taken for each of five replications. Rats were randomly assigned to two treatment groups in equal numbers, there being five rats per treatment. All rats were given 5 mg./kg. reserpine intraperitoneally, and observed for latency and running times every 15 minutes for six hours. In the experimental group a further injection of 10 mg./kg. methyl phenidate intraperitoneally was given at the beginning of the seventh hour from the start of the experiment. Latency and running time were recorded every five minutes for one hour. The control treatment group received I ml. of saline intraperitoneally at the beginning of the seventh hour from the start of the experiment. Latency and running times were observed for one hour at five-minute intervals. From the eighth hour after the experiment rats were tested every 15 minutes until 12 hours had elapsed from the start of the experiment.
The standard dose of 5 mg./kg. of reserpine was used. The administration of 10 mg./kg. methyl phenidate was determined by a series of preliminary trials in which it was found that doses of the order of 12 mg./kg. and above produced some symptoms of locomotor excitation. Doses below 10 mg./kg. were found to affect reserpine pre-treated rats in a manner too ambiguous to evaluate with the testing procedure used. The dosage employed was only 10% of the dosage level required for an L.D. 50 mg./kg. for the equivalent route of administration.
Results.-The results may be found in Table IX . It is apparent that the effects of methyl phenidate administration are distinctly different from the control saline-injected group. No alteration in the state of reserpine-treated animals was found at any time after administration of saline. The effect of methyl phenidate is extraordinarily rapid, having an onset of between two and three minutes. The duration of the drug's effect is approximately 15 to 20 minutes after which the effects of the administration of reserpine slowly reappear. The data have been graphed (Fig. 6) . Running times were immediately affected; rats were able to move on their first trial after methyl phenidate.
Discussion.
-Methyl phenidate appears to have a high specificity for the cerebral environment. The group.bmj.com on April 2, 2017 -Published by http://jnnp.bmj.com/ Downloaded from facilitated the parasympathetic centres as determined by the evoked blood pressure (Anand, Dua, and Malhotra, 1957) .
Two issues arise out of the foregoing discussion, and these must be at least speculatively treated. These issues embrace first, the role 5-hydroxytryptamine (5 HT) and noradrenaline may play in determining the central neurohumoral balance, and secondly, the influence any ensuing neurohumoral disturbance could be considered to have on behaviour.
In any appraisal of reserpine effects the first consideration to be stated is that the disturbance in neurohumoral balance induced by the drug is not occasioned by its presence as such. It has already been accounted that reserpine is rapidly metabolized out of the system, leaving behind an altered state in a number of cerebral amines (Glow, 1957 A number of neurohumoral-like activities have been attributed to 5 HT via the release and increased turnover of the substance by reserpine or the administration of the precursor 5 hydroxytryptophan. Some of these effects are a type of sedation, decrease in depth and rate of respiration, reduction in arterial blood pressure, slowing of the heat and a fall in deep body temperature, etc. From the above effects it could be inferred that 5 HT is normally involved in the regulation of the subcortical centres responsible for alerting, temperature regulation, blood pressure, and similar autonomic functions of the parasympathetic system.
The question may be asked, What is the nature of this 5 HT regulatory function ? Welsh (1957) has to some extent demonstrated that 5 HT or a compound remarkably similar to it has a neurohumoral transmitter role in invertebrates, though a similar function of 5 HT has as yet not been clearly recognized in the central nervous system of vertebrates. Several authors have, however, argued that in the absence of any established alternative the role of a neurohumoral transmitter in the central parasympathetic division of the autonomic nervous system could be assigned to 5 HT .
The suggestion has also been made that noradrenaline could be the chemical mediator in the central sympathetic division of the autonomic nervous system. In view of the lack of any contrary evidence this could be a reasonable working assumption.
If these views are consistent and reasonable reserpine can be considered to have an effect on the chemical mediators of both the central representations of the parasympathetic and sympathetic systems. In view of this possibility it is not unreasonable to entertain the proposition that the results of treatment with reserpine can leave a profound residual effect on the balance and tone of the autonomic nervous system, the effect being that of depletion of the sympathetic transmitter substance and an augmentation of the parasympathetic transmitter. This imbalance can be compensated for by the administration of a suitable central sympathomimetic agent, methyl phenidate.
PART III: EFFECTS OF d-LYSERGIC ACID DIETHYLAMIDE AFTER PREMEDICATION WITH RESERPINE
The data concerning the concentrations of the cerebral amines set out in Part II are of particular interest because it is possible to investigate systematically the hypothesis which has linked the action of the hallucinogen lysergic acid diethylamide (LSD-25) with the presence of endogenous cerebral 5 HT.
Repeatedly attention has been drawn to the existence of a strong antagonism between LSD-25 and 5 HT on peripheral excised tissues, such as rat uterus (Woolley and Shaw, 1954) . These authors proposed that the peculiar psychological properties of LSD-25 may well arise from a similar antagonism in the central nervous system. A simple experiment to test this hypothesis, by administering exogenous 5 HT, cannot be undertaken as the substance is blocked from the cerebral environment by the selective permeability of the blood-brain barrier. Consequently it has been necessary to consider methods whereby variations in cerebral 5 HT activity could be brought about.
EFFECTS OF ACUTE RESERPINE TREATMENT ON BEHAVIOUR Experiment
In view of the fact that reserpine destroys the 5 HT bonding capacity of cerebral tissues, inducing thereby an alteration in the level of the activity of the substance (Brodie, Pletscher, and Shore, 1956; Udenfriend, Weissbach, and Bogdanski, 1957) , it is possible to investigate the effects of LSD-25 during the seven-day recovery period. Under these conditions it should be possible systematically to vary cerebral 5 HT, and test the animal for any differential behavioural reactivity to LSD-25. Clearly the hypothesis generated under these circumstances predicts that the behavioural decrements induced by LSD-25 in the rat will be greater at a time when the least reformation of 5 HT bonding sites has occurred, that is when 5 HT activity is greatest. For this purpose response latencies and locomotor times have been used as behavioural indices using a straight runway technique developed by the author (Glow, 1957) .
Design.-This experiment took place over a period of six weeks. As the same population of rats was employed three times, in order to ensure complete recovery between experimental phases, two weeks' recovery was permitted.
All rats received 5 mg./kg. of reserpine administered intraperitoneally. The rats were permitted to " recover " for a given period of time and tested on the apparatus. The experimental animals were divided into two treatment groups. One group received 62-5 fLg./kg.; the other group received 250 zg./kg. LSD-25. The control group received an equal volume of distilled water. A control group was subsequently run to demonstrate the effect of LSD-25 treatment omitting the premedication with reserpine. At the conclusion of one experimental phase the rats were permitted to rest from any further drug treatment for two weeks, whereupon the entire population was re-randomized for the next phase.
The phases of the experiment consisted of a given constant time from when the effect of reserpine was no longer apparent, and these were calculated from the times of injection.
Phase 1 was 48 hours after reserpine administration 2 ,, 72 ,.
,, 3 ,, 96 9,. . ... The reserpine pre-treatments were constant in all phases, but the post-recovery period varied progressively by 24 hours over the three phases of the experiment. No consideration was paid to litter mate controls, as it was considered more important to ensure complete randomization over the three phases. This was necessitated by the loss of two animals during the training. The design has been set out in Table X. During each experimental phase the following procedure was adopted. All animals were run three times without the LSD-25 treatment in order to ensure that the effect of the reserpine pre-treatment was no longer apparent in the latency or running times. The mean of these runs was calculated and regarded as the " normal " performance level of the rat. After treatment had been instigated, i.e., when a given dosage of LSD-25 had been administered, samples of the animals' latency and running times were taken. The drug dosages for both reserpine and LSD-25 were calculated on the basis of the findings made with these drugs in earlier experiments. The use of 5 mg./kg. of reserpine, although a severe dose, was found useful, as in the previous study it was found that all rats recovered within 36 hours. The two LSD-25 treatments represented the lowest and a middle range dose employed in the experiments reported previously (Glow, 1957) . The characteristic latency and running times under these dosages were known, and were consequently suitable for comparison.
A noise generator was used under the same conditions as those of previous experiments. Rats were permitted up to five minutes' latency, and then received the stimulus for a further period of two minutes, and if after that time no response was made the trial was terminated. At least 10 observations were made with each subject, though those who had not recovered by the tenth trial were taken on until they had done so. Control runs were only made for seven successive trials. This is in conformity with the number of observations made in the experiments with LSD-25 made by the author and already referred to.
The subjects of this experiment were from a population of 20 rats obtained at weaning from the same source as the group used in the previous experiments. The training apparatus and handling procedures employed were identical with those previously described (Glow, 1957) .
Results.-The results are expressed in terms of latency and running times.
Latency.-In (Fig. 9 ). This curious trend does not persist in either phase 2 or phase 3. In these phases the disturbance of the curves plotted is in the expected direction, namely the higher the dose the more intense the disturbance (Figs. 10  and 11) .
Another aspect from which the data can be examined is the recovery times from both the treatment and the phase variables. In Table XII The specific hypothesis tested was whether recovery from LSD disturbance is a function of the interval between reserpine pre-treatment and LSD-25 administration. The analysis of variance is set out in Table XIII. It is apparent from the trend found when examining the data for intensity that it holds good when the data are examined from the point of view of recovery, i.e., along the time dimension. The disturbances persist for considerably longer the closer the interval between reserpine pre-treatment and LSD-25 administration. A similar trend is by no means clear when examining the data along the Discussion.-Data have been brought forward to substantiate to some degree the hypothesis posed. It has been possible to demonstrate that the effect of premedication with reserpine measurably alters the course of the LSD-25 disturbance. The data revealed an increase in two types of measures, an increase in intensity over a given period and an increase in the total duration. By and large this increase is in the expected order, namely, the higher the dose of LSD-25 the more profound the effect. Similarly, an ordered relationship has been found along the phase variable, so that the intensityduration increase decreased over the successive experimental phases.
There is a clear indication that some aspects of the disturbances produced by administration of the LSD-25 are considerably enhanced by premedication with reserpine. Isbell and Logan (1957) recently obtained similar results in experiments conducted with adult male drug addicts serving sentences. His subjects found the combination of drugs, given in the order of 6 mg. reserpine, and, after 22 hours 0-5 ,ug./kg. LSD-25, considerably more disturbing than when LSD was given exclusively. Isbell utilized a questionnaire technique to assess the intensity of the disturbance.
With these findings in mind it is reasonable to assume that the effects of reserpine pre-treatment somehow alter the intensity-duration of the disturbance induced by LSD-25. It remains then to suggest the possible mechanism which may determine this disturbance. The evidence to date has been discussed in the introduction to this paper. Briefly stated, the assumption made was that reserpine destroys the bonding mechanism required to store 5 HT, thereby releasing it for rapid metabolism . It is further suggested that reserpine of itself has no effect on the central nervous system for a period longer than approximately two hours after administration (Sheppard, Lucas, and Tsien, 1955) . The reformation of bonding sites takes place over a considerable time span, during which there is a proportionately greater production and turnover of free 5 HT (Udenfriend et al., 1957) . If the peripheral effects of LSD-25 in the presence of free 5 HT, e.g., on the excised rat uterus, are also the type of effects the substance has in vivo, i.e., in cerebral tissue of the intact rat, then the disturbance produced by LSD-25 will be to some degree proportional to the amount of active 5 HT in the central nervous system. The evidence arising out of the injection of LSD-25 at three distinct points in time during which this reformation of 5 HT bonding sites occurs seems to justify the two following propositions, namely, that an interaction between LSD-25 and 5 HT occurring in the central nervous system appears to be of a similar kind to that found on excised peripheral tissue and that the degree of effect as measured by behavioural indices is relative to a change in 5 HT in the central nervous system. There is very little clarification about the nature of the interaction of LSD-25 and free 5 HT in the central nervous system. Even the most recent findings reported by Woolley and Shaw (1957) have not indicated the direction of the interaction between these two substances. These authors report on experiments conducted on excised human foetal brain cells. Oligodendroglia are cells which are usually regarded as the structural supports to the active neural bodies. Recent findings with time-lapse photography have shown that these cells have a continuous rhythmic pulsating action. Woolley and Shaw have demonstrated that free 5 HT produces tetanic-like seizures of these pulsating cells. On the topic administration of LSD-25 in conjunction with free 5 HT there was some indication that at certain dose levels and varying times of administration, 5 HT activity facilitated and at other levels and times there is an antagonism. This is precisely analogous to the state of affairs in peripheral tissues like the rat uterus. However, as there is little known either about the function of oligodendroglia or the effects of drugs on them there is little point in further speculation now. In Part II the author has pointed out that there is a distinct possibility that 5 HT may be a chemical mediator for the central representation of the autonomic nervous system. In this event the peculiar psychological effects of LSD-25 may be occasioned through its capacity to act as a specific blocking agent to 5 HT or bio-electric inhibitor.
Conclusion
The theory has been current in recent years that the behavioural disturbances produced by LSD-25 are mediated by an antagonism with 5 hydroxytryptamine in the central nervous system. This 
